Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2025-12-25 @ 7:45 PM
Study NCT ID:
NCT00779935
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2008-10-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2005-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-23
First Submit QC Date:
None
Study First Post Date:
2008-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-10
Last Update Post Date:
2017-05-11
Last Update Post Date Type:
ACTUAL